← Eichor
Study identifier: NCT07661108 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)

Condition: Healthy  ·  Sponsor: Merck Sharp & Dohme LLC

PhasePhase 1
Planned participants44
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersYes

About this study

Researchers are studying a medicine called MK-8527 to learn how it behaves in the body of healthy adults. The goal of this study is to learn about the effect of MK-8527 when it is taken with food or with other medicines. Researchers also want to learn about the safety of MK-8527 and if people tolerate it. Tolerate means participants will receive treatment in the trial unless they need to stop it due to health problems.

This description comes directly from the study's public registry record.

Talk to the study team

Toll Free Number  ·  1-888-577-8839  ·  Trialsites@msd.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fortrea Clinical Research Unit Inc ( Site 0001)Daytona Beach, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07661108